Osteoporosis in anorexia nervosa

References

• Melton LJ 3rd, Thamer M, Ray NF et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J. Bone Miner. Res.12(1), 16–23 (1997).
   PubMed Web of Science ®Google Scholar
• Bone Health and Osteoporosis: A Report of the Surgeon General. US Department of Health and Human Services, Office of the Surgeon General, MD, USA (2004).
   Google Scholar
• Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J. Bone Miner. Res.15(11), 2245–2250 (2000).
   PubMed Web of Science ®Google Scholar
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser.843, 1–129 (1994).
   PubMed Web of Science ®Google Scholar
• Jayasinghe Y, Grover SR, Zacharin M. Current concepts in bone and reproductive health in adolescents with anorexia nervosa. BJOG115(3), 304–315 (2008).
   PubMed Web of Science ®Google Scholar
• Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J. Bone Miner. Res.7(2), 137–145 (1992).
   PubMed Web of Science ®Google Scholar
• Molgaard C, Thomsen BL, Prentice A, Cole TJ, Michaelsen KF. Whole body bone mineral content in healthy children and adolescents. Arch. Dis. Child76(1), 9–15 (1997).
   PubMed Web of Science ®Google Scholar
• Zemel BS, Leonard MB, Kelly A et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J. Clin. Endocrinol. Metab.95(3), 1265–1273 (2010).
   PubMed Web of Science ®Google Scholar
• Gordon CM, Bachrach LK, Carpenter TO et al. Dual energy x-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J. Clin. Densitom.11(1), 43–58 (2008).
   PubMed Web of Science ®Google Scholar
• Clark EM, Tobias JH, Ness AR. Association between bone density and fractures in children: a systematic review and meta-analysis. Pediatrics117(2), e291–e297 (2006).
   PubMed Web of Science ®Google Scholar
• Jones G, Ma D, Cameron F. Bone density interpretation and relevance in Caucasian children aged 9–17 years of age: insights from a population-based fracture study. J. Clin. Densitom.9(2), 202–209 (2006).
   Google Scholar
• Flynn J, Foley S, Jones G. Can BMD assessed by DXA at age 8 predict fracture risk in boys and girls during puberty?: an eight-year prospective study. J. Bone Miner. Res.22(9), 1463–1467 (2007).
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders (4th Edition). APA Press, Washington, DC, USA (1994).
   Google Scholar
• Golden NH. Eating disorders in adolescence and their sequelae. Best Pract. Res. Clin. Obstet. Gynaecol.17(1), 57–73 (2003).
   PubMed Web of Science ®Google Scholar
• Scholtz S, Hill LS, Lacey H. Eating disorders in older women: does late onset anorexia nervosa exist? Int. J. Eat. Disord.43(5), 393–397 (2010).
   PubMed Web of Science ®Google Scholar
• Grinspoon S, Thomas E, Pitts S et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann. Intern. Med.133(10), 790–794 (2000).
   PubMed Web of Science ®Google Scholar
• Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker IR. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J. Pediatr. Adolesc. Gynecol.15(3), 135–143 (2002).
   PubMedGoogle Scholar
• Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics86(3), 440–447 (1990).
   Google Scholar
• Grinspoon S, Miller K, Coyle C et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J. Clin. Endocrinol. Metab.84(6), 2049–2055 (1999).
   PubMed Web of Science ®Google Scholar
• Soyka LA, Misra M, Frenchman A et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J. Clin. Endocrinol. Metab.87(9), 4177–4185 (2002).
   PubMed Web of Science ®Google Scholar
• Miller KK, Lee EE, Lawson EA et al. Determinants of skeletal loss and recovery in anorexia nervosa. J. Clin. Endocrinol. Metab.91(8), 2931–2937 (2006).
   Google Scholar
• Andersen AE, Watson T, Schlechte J. Osteoporosis and osteopenia in men with eating disorders. Lancet355(9219), 1967–1968 (2000).
   Google Scholar
• Mehler PS, Sabel AL, Watson T, Andersen AE. High risk of osteoporosis in male patients with eating disorders. Int. J. Eat. Disord.41(7), 666–672 (2008).
   PubMed Web of Science ®Google Scholar
• Misra M, Katzman DK, Cord J et al. Bone metabolism in adolescent boys with anorexia nervosa. J. Clin. Endocrinol. Metab.93(8), 3029–3036 (2008).
   PubMed Web of Science ®Google Scholar
• Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA265(9), 1133–1138 (1991).
   PubMed Web of Science ®Google Scholar
• Bachrach LK, Katzman DK, Litt IF, Guido D, Marcus R. Recovery from osteopenia in adolescent girls with anorexia nervosa. J. Clin. Endocrinol. Metab.72(3), 602–606 (1991).
   PubMed Web of Science ®Google Scholar
• Herzog W, Minne H, Deter C et al. Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J. Bone Miner. Res.8(5), 597–605 (1993).
   PubMed Web of Science ®Google Scholar
• Ward A, Brown N, Treasure J. Persistent osteopenia after recovery from anorexia nervosa. Int. J. Eat. Disord.22(1), 71–75 (1997).
   Google Scholar
• Hartman D, Crisp A, Rooney B, Rackow C, Atkinson R, Patel S. Bone density of women who have recovered from anorexia nervosa. Int. J. Eat. Disord.28(1), 107–112 (2000).
   PubMed Web of Science ®Google Scholar
• Lucas AR, Melton LJ 3rd, Crowson CS, O’Fallon WM. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin. Proc.74(10), 972–977 (1999).
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Emborg C, Stoving RK, Hagen C, Mosekilde L, Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders – a nationwide register study. Int. J. Eat. Disord.32(3), 301–308 (2002).
   Web of Science ®Google Scholar
• Andersen AE, Woodward PJ, LaFrance N. Bone mineral density of eating disorder subgroups. Int. J. Eat. Disord.18(4), 335–342 (1995).
   Google Scholar
• Naessen S, Carlstrom K, Glant R, Jacobsson H, Hirschberg AL. Bone mineral density in bulimic women – influence of endocrine factors and previous anorexia. Eur. J. Endocrinol.155(2), 245–251 (2006).
   PubMedGoogle Scholar
• Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J. Clin. Endocrinol. Metab.81(11), 3864–3870 (1996).
   PubMed Web of Science ®Google Scholar
• Misra M, Aggarwal A, Miller KK et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics114(6), 1574–1583 (2004).
   PubMed Web of Science ®Google Scholar
• Cadogan J, Eastell R, Jones N, Barker ME. Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. BMJ315(7118), 1255–1260 (1997).
   PubMed Web of Science ®Google Scholar
• Johnston CC Jr, Miller JZ, Slemenda CW et al. Calcium supplementation and increases in bone mineral density in children. N. Engl. J. Med.327(2), 82–87 (1992).
   PubMed Web of Science ®Google Scholar
• Lloyd T, Andon MB, Rollings N et al. Calcium supplementation and bone mineral density in adolescent girls. JAMA270(7), 841–844 (1993).
   PubMed Web of Science ®Google Scholar
• Hadigan CM, Anderson EJ, Miller KK et al. Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int. J. Eat. Disord.28(3), 284–292 (2000).
   Google Scholar
• Misra M, Prabhakaran R, Miller KK et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J. Clin. Endocrinol. Metab.93(4), 1231–1237 (2008).
   PubMed Web of Science ®Google Scholar
• Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch. Pediatr. Adolesc. Med.158(6), 531–537 (2004).
   PubMedGoogle Scholar
• Holick MF. Vitamin D deficiency. N. Engl. J. Med.357(3), 266–281 (2007).
   PubMed Web of Science ®Google Scholar
• Haagensen AL, Feldman HA, Ringelheim J, Gordon CM. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporos. Int.19(3), 289–294 (2008).
   Google Scholar
• Golden NH, Kreitzer P, Jacobson MS et al. Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa. J. Pediatr.125(4), 655–660 (1994).
   PubMed Web of Science ®Google Scholar
• Glastre C, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD. Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. J. Clin. Endocrinol. Metab.70(5), 1330–1333 (1990).
   PubMed Web of Science ®Google Scholar
• Southard RN, Morris JD, Mahan JD et al. Bone mass in healthy children: measurement with quantitative DXA. Radiology179(3), 735–738 (1991).
   PubMed Web of Science ®Google Scholar
• Henderson NK, Price RI, Cole JH, Gutteridge DH, Bhagat CI. Bone density in young women is associated with body weight and muscle strength but not dietary intakes. J. Bone Miner. Res.10(3), 384–393 (1995).
   PubMed Web of Science ®Google Scholar
• Moro M, van der Meulen MC, Kiratli BJ, Marcus R, Bachrach LK, Carter DR. Body mass is the primary determinant of midfemoral bone acquisition during adolescent growth. Bone19(5), 519–526 (1996).
   PubMed Web of Science ®Google Scholar
• Goebel G, Schweiger U, Kruger R, Fichter MM. Predictors of bone mineral density in patients with eating disorders. Int. J. Eat. Disord.25(2), 143–150 (1999).
   Google Scholar
• Turner JM, Bulsara MK, McDermott BM, Byrne GC, Prince RL, Forbes DA. Predictors of low bone density in young adolescent females with anorexia nervosa and other dieting disorders. Int. J. Eat. Disord.30(3), 245–251 (2001).
   PubMed Web of Science ®Google Scholar
• Gordon CM, Grace E, Emans SJ et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J. Clin. Endocrinol. Metab.87(11), 4935–4941 (2002).
   PubMed Web of Science ®Google Scholar
• Golden NH, Iglesias EA, Jacobson MS et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab.90(6), 3179–3185 (2005).
   Google Scholar
• Biller BM, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J. Clin. Endocrinol. Metab.68(3), 548–554 (1989).
   PubMed Web of Science ®Google Scholar
• Mehler PS, MacKenzie TD. Treatment of osteopenia and osteoporosis in anorexia nervosa: a systematic review of the literature. Int. J. Eat. Disord.42(3), 195–201 (2009).
   PubMed Web of Science ®Google Scholar
• Mika C, Holtkamp K, Heer M, Gunther RW, Herpertz-Dahlmann B. A 2-year prospective study of bone metabolism and bone mineral density in adolescents with anorexia nervosa. J. Neural Transm.114(12), 1611–1618 (2007).
   PubMed Web of Science ®Google Scholar
• Compston JE, McConachie C, Stott C et al. Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos. Int.17(1), 77–84 (2006).
   Google Scholar
• Viljakainen HT, Natri AM, Karkkainen M et al. A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention. J. Bone Miner. Res.21(6), 836–844 (2006).
   PubMedGoogle Scholar
• Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics122(5), 1142–1152 (2008).
   PubMed Web of Science ®Google Scholar
• McKay HA, Petit MA, Schutz RW, Prior JC, Barr SI, Khan KM. Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children. J. Pediatr.136(2), 156–162 (2000).
   PubMed Web of Science ®Google Scholar
• Christo K, Prabhakaran R, Lamparello B et al. Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics121(6), 1127–1136 (2008).
   PubMedGoogle Scholar
• DiVasta AD, Feldman HA, Quach AE, Balestrino M, Gordon CM. The effect of bed rest on bone turnover in young women hospitalized for anorexia nervosa: a pilot study. J. Clin. Endocrinol. Metab.94(5), 1650–1655 (2009).
   PubMedGoogle Scholar
• Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J. Clin. Endocrinol. Metab.87(6), 2883–2891 (2002).
   PubMed Web of Science ®Google Scholar
• Gordon CM, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J. Bone Miner. Res.14(1), 136–145 (1999).
   PubMed Web of Science ®Google Scholar
• Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J. Clin. Endocrinol. Metab.90(3), 1428–1433 (2005).
   PubMed Web of Science ®Google Scholar
• Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J. Clin. Endocrinol. Metab.80(3), 898–904 (1995).
   PubMed Web of Science ®Google Scholar
• Strokosch GR, Friedman AJ, Wu SC, Kamin M. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J. Adolesc. Health39(6), 819–827 (2006).
   PubMed Web of Science ®Google Scholar
• Harel Z, Riggs S, Vaz R, Flanagan P, Harel D, Machan JT. Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study. J. Pediatr. Adolesc. Gynecol.23(1), 23–31 (2010).
   Web of Science ®Google Scholar
• Bianchi ML, Cimaz R, Bardare M et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum.43(9), 1960–1966 (2000).
   PubMed Web of Science ®Google Scholar
• Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N. Engl. J. Med.339(14), 947–952 (1998).
   PubMed Web of Science ®Google Scholar
• Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J. Pediatr.141(5), 644–651 (2002).
   PubMed Web of Science ®Google Scholar
• Miller KK, Grieco KA, Mulder J et al. Effects of risedronate on bone density in anorexia nervosa. J. Clin. Endocrinol. Metab.89(8), 3903–3906 (2004).
   Google Scholar
• Batch JA, Couper JJ, Rodda C, Cowell CT, Zacharin M. Use of bisphosphonate therapy for osteoporosis in childhood and adolescence. J. Paediatr. Child Health39(2), 88–92 (2003).
   PubMed Web of Science ®Google Scholar
• Brumsen C, Hamdy NA, Papapoulos SE. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine (Baltimore)76(4), 266–283 (1997).
   PubMed Web of Science ®Google Scholar
• Munns CF, Rauch F, Ward L, Glorieux FH. Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases. J. Bone Miner. Res.19(10), 1742–1745 (2004).
   PubMed Web of Science ®Google Scholar
• Ornoy A, Wajnberg R, Diav-Citrin O. The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment. Reprod. Toxicol.22(4), 578–579 (2006).
   PubMed Web of Science ®Google Scholar
• Levy S, Fayez I, Taguchi N et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone44(3), 428–430 (2009).
   PubMed Web of Science ®Google Scholar
• Chan B, Zacharin M. Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J. Clin. Endocrinol. Metab.91(6), 2017–2020 (2006).
   PubMed Web of Science ®Google Scholar
• Chahine C, Cheung MS, Head TW, Schwartz S, Glorieux FH, Rauch F. Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J. Pediatr.153(5), 719–720 (2008).
   Google Scholar
• Malmgren B, Astrom E, Soderhall S. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J. Oral Pathol. Med.37(4), 196–200 (2008).
   Google Scholar
• Brown JJ, Ramalingam L, Zacharin MR. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Clin. Endocrinol. (Oxf.)68(6), 863–867 (2008).
   Google Scholar
• Schwartz S, Joseph C, Iera D, Vu DD. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series. J. Can. Dent. Assoc.74(6), 537–542 (2008).
   Google Scholar
• Li X, Ominsky MS, Warmington KS et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J. Bone Miner. Res.24(4), 578–588 (2009).
   PubMed Web of Science ®Google Scholar
• Iketani T, Kiriike N, Stein MB et al. Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Res.117, 259–269 (2003).
   Google Scholar